Bio-Rad Laboratories Newsroom

Bio-Rad Laboratories Analyst Ratings

BenzingaDec 9 21:49

RBC Capital Maintains Bio-Rad Laboratories(BIO.US) With Buy Rating, Raises Target Price to $481

Futu NewsDec 9 20:33

RBC Raises Price Target on Bio-Rad Laboratories to $481 From $469, Keeps Outperform Rating

MT NewswiresDec 9 20:16

A Quick Look at Today's Ratings for Bio-Rad Laboratories(BIO.US), With a Forecast Between $360 to $469

Futu NewsNov 1 21:18

Bio-Rad Laboratories Is Maintained at Outperform by RBC Capital

Dow JonesNov 1 03:49

Bio-Rad Laboratories Analyst Ratings

BenzingaNov 1 03:40

RBC Capital Maintains Bio-Rad Laboratories(BIO.US) With Buy Rating, Raises Target Price to $469

Futu NewsOct 31 19:33

Citi Maintains Bio-Rad Laboratories(BIO.US) With Buy Rating, Raises Target Price to $450

Futu NewsOct 31 19:33

RBC Capital Maintains Bio-Rad Laboratories(BIO.US) With Buy Rating, Raises Target Price to $446

Futu NewsOct 25 10:32

Bio-Rad Laboratories (BIO) Gets a Buy From RBC Capital

TipRanksOct 25 09:59

Analysts Offer Insights on Healthcare Companies: Xencor (XNCR), Argenica Therapeutics Ltd (AU:AGN) and Bio-Rad Laboratories (BIO)

TipRanksOct 8 17:04

Bio-Rad Upped by Citi to Buy; Charles River, Hologic Downgraded

Seeking AlphaOct 2 06:38

Bio-Rad Laboratories Analyst Ratings

BenzingaOct 1 21:27

Citi Upgrades Bio-Rad Laboratories(BIO.US) to Buy Rating, Raises Target Price to $400

Futu NewsOct 1 18:31

Nephron Initiates Bio-Rad Laboratories(BIO.US) With Buy Rating, Announces Target Price $390

Futu NewsAug 29 02:31

Jefferies Maintains Bio-Rad Laboratories(BIO.US) With Hold Rating, Raises Target Price to $340

Futu NewsAug 28 18:31

Bio-Rad Laboratories Analyst Ratings

BenzingaAug 16 23:14

RBC Capital Maintains Bio-Rad Laboratories(BIO.US) With Buy Rating, Maintains Target Price $401

Futu NewsAug 16 19:31

Bio-Rad Laboratories (BIO) Receives a Buy From RBC Capital

TipRanksAug 16 18:50

Bio-Rad Laboratories Price Target Cut to $401.00/Share From $402.00 by RBC Capital

Dow JonesAug 3 03:58